Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Ginkgo Bioworks
DNA
|
$1.05B |
| 2 |
Peloton Interactive
PTON
|
$691M |
| 3 |
DoorDash
DASH
|
$456M |
| 4 |
Certara
CERT
|
$393M |
| 5 |
Service Corp International
SCI
|
$374M |
Top Sells
| 1 |
Alibaba
BABA
|
$2.33B |
| 2 |
Tesla
TSLA
|
$1.55B |
| 3 |
Moderna
MRNA
|
$1.41B |
| 4 |
Amazon
AMZN
|
$884M |
| 5 |
NetEase
NTES
|
$692M |
Sector Composition
| 1 | Consumer Discretionary | 27.71% |
| 2 | Healthcare | 26.02% |
| 3 | Technology | 19.32% |
| 4 | Communication Services | 12.04% |
| 5 | Financials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Bumble
BMBL
$672M
| $20M | 0.01% |
400,000
| – | – |
|
227
Health Catalyst
HCAT
$232M
| $19.1M | 0.01% |
381,003
+81,441
| +27% | +$4.07M |
|
228
Stratasys
SSYS
$866M
| $18.8M | 0.01% |
874,383
-13,969
| -2% | -$301K |
|
229
FirstCash
FCFS
$6.69B
| $18.8M | 0.01% |
214,587
-106,396
| -33% | -$9.31M |
|
230
Axogen
AXGN
$709M
| $18.4M | 0.01% |
1,161,659
-4,578
| -0.4% | -$72.3K |
|
231
Royal Caribbean
RCL
$97.8B
| $16.8M | 0.01% |
188,339
-87,860
| -32% | -$7.82M |
|
|
SIX
232
DELISTED
Six Flags Entertainment Corp.
SIX
| $16.4M | 0.01% |
385,701
-183,919
| -32% | -$7.82M |
|
233
Align Technology
ALGN
$9.76B
| $16.4M | 0.01% |
24,631
-2,723
| -10% | -$1.81M |
|
|
NBTX
234
Nanobiotix
NBTX
$411M
| $15.9M | 0.01% |
1,400,000
| – | – |
|
|
CLLS
235
Cellectis
CLLS
$264M
| $13.6M | 0.01% |
1,076,525
+42,653
| +4% | +$538K |
|
236
HUTCHMED
HCM
$2.55B
| $13.5M | 0.01% |
367,965
+707
| +0.2% | +$25.9K |
|
237
Ascendis Pharma
ASND
$12B
| $13.3M | 0.01% |
83,434
+8,882
| +12% | +$1.42M |
|
238
Cooper Companies
COO
$13.5B
| $13M | 0.01% |
125,492
-6,916
| -5% | -$715K |
|
239
Sherwin-Williams
SHW
$91.2B
| $12.4M | 0.01% |
44,453
-2,933
| -6% | -$820K |
|
|
OCFT
240
OneConnect Financial Technology
OCFT
$277M
| $12.2M | 0.01% |
297,315
-705
| -0.2% | -$28.9K |
|
241
Visa
V
$681B
| $11.7M | 0.01% |
52,510
-3,340
| -6% | -$744K |
|
242
Burford Capital
BUR
$2.91B
| $11.3M | 0.01% |
1,038,109
+247,489
| +31% | +$2.7M |
|
243
Veeva Systems
VEEV
$44.3B
| $11.1M | 0.01% |
38,471
+4,188
| +12% | +$1.21M |
|
244
Spire Global
SPIR
$272M
| $10.9M | 0.01% |
+108,256
| New | +$10.9M |
|
|
KDNY
245
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $10.7M | 0.01% |
837,576
-1,804
| -0.2% | -$23K |
|
246
DT Midstream
DTM
$10.7B
| $10.6M | 0.01% |
+229,294
| New | +$10.6M |
|
|
BNFT
247
DELISTED
Benefitfocus, Inc.
BNFT
| $10.4M | 0.01% |
940,392
-4,014
| -0.4% | -$44.6K |
|
248
Ionis Pharmaceuticals
IONS
$9.46B
| $10.1M | 0.01% |
302,003
+30,607
| +11% | +$1.03M |
|
249
Verisk Analytics
VRSK
$37.7B
| $10.1M | 0.01% |
50,495
-3,768
| -7% | -$755K |
|
|
DCBO
250
Docebo
DCBO
$894M
| $9.89M | 0.01% |
135,418
+21,483
| +19% | +$1.57M |
|